AcelRx Pharmaceuticals, Inc. Price Today
AcelRx Pharmaceuticals, Inc.
ACRX
Healthcare
$8.11M
💰
Market Cap
0
💸
Price to Earnings
$-3.3
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
4 |
Strong Buy |
2 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
ACRX Price Forecast Target
0.5 👉 5.0 +907%
ACRX EPS Forecast
-3.3 👉 -0.9 +-72%
Financials
Profit Margin
0 %
Revenue Growth
-55.6 %
Dividend
$ 0
Held Percent
0.9% - Insiders
10.1% - Institutions
89.0% - Public
Major Fund Holders
-
💰 Rock Springs Capital Management, LP $351,270.0
-
💰 Tang Capital Management, LLC $216,450.0
-
💰 Vanguard Group Inc $174,832.0
-
💰 Values First Advisors, Inc. $135,909.0
-
💰 Blackrock Inc. $102,217.0
Stock Ideas
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…📮FAQ
Some Frequently Asked Questions.
The AcelRx Pharmaceuticals, Inc. industry is Drug Manufacturers—Specialty & Generic
The AcelRx Pharmaceuticals, Inc. sector is Healthcare
The AcelRx Pharmaceuticals, Inc. forecasted predicted Price to Earnings PE ratio is -0.5
The AcelRx Pharmaceuticals, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of AcelRx Pharmaceuticals, Inc. is $8.11M
There are total of 12589407 float shares with 10.1% held by Institutions and 0.9% held by insiders
The MAcelRx Pharmaceuticals, Inc. forecasted Earnings per Share EPS is $-0.9
The AcelRx Pharmaceuticals, Inc. Earnings per Share EPS is -3.3
The AcelRx Pharmaceuticals, Inc. company has $-3341000 gross profits with 0 profit margins
The AcelRx Pharmaceuticals, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The AcelRx Pharmaceuticals, Inc. Revenue is $253000 with -0.556 revenue growth
The price target for AcelRx Pharmaceuticals, Inc. stock is $5.0 for the high target and $4.2 for the low target
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AcelRx Pharmaceuticals, Inc. is Buy, with the following breakdown:
- Buy: 4
- Strong Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of AcelRx Pharmaceuticals, Inc. is 0.4
The dividend of AcelRx Pharmaceuticals, Inc. is $0
The dividend yield of AcelRx Pharmaceuticals, Inc. is 0%
The biggest institutional and mutual fund holders of AcelRx Pharmaceuticals, Inc. stock are
- Rock Springs Capital Management, LP
- Tang Capital Management, LLC
- Vanguard Group Inc
- Values First Advisors, Inc.
The AcelRx Pharmaceuticals, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0